The global biosimilar and biologics market is projected to grow from USD 561.7 billion in 2025 to USD 1,157.4 billion by 2035, registering a robust CAGR of 7.6% over the forecast period. This impressive expansion is being driven by rising global demand for targeted therapies, increasing prevalence of chronic diseases, and the accelerated regulatory approvals …
Continue reading “Biosimilar and Biologics Market to Reach USD 1,157.4B by 2035 at 7.6% CAGR”